Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
 
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research
 
Back

Nanotech News


June 2012

Additional Publications of Note for June

Therapeutics

Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
International Journal of Pharmaceutics
View abstract

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD(2) coated nanoparticles.
PLoS One
View paper

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs.
International Journal of Nanomedicine
View paper

Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.
Investigational New Drugs
View abstract

Lipid-based nanoparticle delivery of pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma.
Molecular Therapy
View abstract

Vincristine-sulphate-loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system
Journal of Liposome Research
View abstract

Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy.
ACS Nano
View abstract

Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
Journal of Controlled Release
View abstract

Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.
Molecular Pharmaceutics
View abstract

Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.
International Journal of Nanomedicine
View abstract

β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: stability, target-activated release and cytotoxicity.
European Journal of Pharmaceutics and Biopharmaceutics
View abstract

Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery
Proceedings of the National Academies of Science
View abstract

Diagnostics and Biosensors

Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticles.
ACS Nano
View abstract

Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.
Analytical Biochemistry
View abstract

Real-time cell analysis of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles
Anticancer Research
View abstract

Imaging

Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T(1)-weighted MR and photoluminescence imaging.
Biomaterials
View abstract

Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy.
International Journal of Nanomedicine
View paper

The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.
ACS Nano
View abstract

Estimation of minimum doses for optimized quantum dot contrast-enhanced vascular imaging in vivo
Small
View abstract

In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene
Biomaterials
View abstract

New clathrin-based nanoplatforms for magnetic resonance imaging
PLoS One
View paper

Nano Devices and Materials

Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores
Langmuir
View abstract

Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.
Journal of the American Chemical Society
View abstract

Nanobiology

Tumor necrosis factor interaction with gold nanoparticles.
Nanoscale
View abstract

Ionizing radiation increases systemic nanoparticle tumor accumulation.
Nanomedicine
View abstract

Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand.
Nano Letters
View abstract

Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties
Molecular Pharmaceutics
View abstract